.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Find suppliers and generic API sources
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Citi
Moodys
Medtronic
Dow
Healthtrust
AstraZeneca
Cantor Fitzgerald
Cipla
Chubb

Generated: June 23, 2017

DrugPatentWatch Database Preview

ATIVAN Drug Profile

« Back to Dashboard

Which patents cover Ativan, and what generic Ativan alternatives are available?

Ativan is a drug marketed by West-ward Pharms Int and Valeant Intl and is included in two NDAs.

The generic ingredient in ATIVAN is lorazepam. There are eleven drug master file entries for this compound. Fifty-six suppliers are listed for this compound. Additional details are available on the lorazepam profile page.

Summary for Tradename: ATIVAN

Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list7
Bulk Api Vendors: see list27
Clinical Trials: see list17
Patent Applications: see list5,539
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ATIVAN at DailyMed

Pharmacology for Tradename: ATIVAN

Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int
ATIVAN
lorazepam
INJECTABLE;INJECTION018140-001Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe
Valeant Intl
ATIVAN
lorazepam
TABLET;ORAL017794-002Approved Prior to Jan 1, 1982ABRXYesNo► Subscribe► Subscribe
West-ward Pharms Int
ATIVAN
lorazepam
INJECTABLE;INJECTION018140-002Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe
Valeant Intl
ATIVAN
lorazepam
TABLET;ORAL017794-001Approved Prior to Jan 1, 1982ABRXYesNo► Subscribe► Subscribe
Valeant Intl
ATIVAN
lorazepam
TABLET;ORAL017794-003Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ATIVAN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
West-ward Pharms Int
ATIVAN
lorazepam
INJECTABLE;INJECTION018140-001Approved Prior to Jan 1, 19824,017,616► Subscribe
West-ward Pharms Int
ATIVAN
lorazepam
INJECTABLE;INJECTION018140-002Approved Prior to Jan 1, 19824,017,616► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Colorcon
Covington
Cantor Fitzgerald
Accenture
Johnson and Johnson
Fuji
Boehringer Ingelheim
AstraZeneca
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot